The Future of Endometrial Cancer Treatment
Experts give insight on what they are looking forward to in the endometrial cancer space.
A Look at Surgical Innovations in EC
Nicoletta Colombo, MD, PhD, reviews surgical advancements in endometrial cancer.
Novel Targets of Interest in EC
Experts in endometrial cancer comment on novel targets of interest that are currently being investigated.
Insight on Ongoing Trials in EC
Key opinion leaders take a look at the evolving treatment landscape in endometrial cancer, discussing ongoing trials in the space.
Incorporating Molecular Features into Choosing Adjuvant Therapy
Experts discuss the importance of incorporating molecular features into the selection of adjuvant treatment.
Therapeutic Sequencing in Endometrial Cancer
Experts in endometrial cancer comment on therapeutic sequencing in endometrial cancer.
Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer
Neoadjuvant Nivolumab Plus Carboplatin/Paclitaxel Elicits High pCR Rates in Early-Stage TNBC
Dr Schmid on the Use of Perioperative Pembrolizumab in TNBC
Dr Khan on Optimizing Local Therapy Using MRI and a 12-Gene Expression Assay in DCIS
2 Clarke Drive Cranbury, NJ 08512